Contact this trialFirst, we need to learn more about you.
Antimalarial
Hydroxychloroquine for COVID-19
Recruiting3 awardsPhase 3
New York, New York
This trial will test if taking hydroxychloroquine (HCQ) once a day can prevent COVID-19 infection in hospital workers. 374 workers will be given either HCQ or a placebo and followed for 90 days. The trial will compare the number of infected workers in each group.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.